RI-MUHC cancer genetics expert honoured by UBC
Dr. William Foulkes receives the 2022 Dr. Chew Wei Memorial Prize in Cancer Research
RI-MUHC study highlights the role of fat metabolism enzyme in aggressive prostate cancer
A fatty acid metabolism enzyme drives prostate cancer aggressiveness...
RI-MUHC trainee awarded 2022 Vanier Canada Graduate Scholarship
Joan Miguel Romero is investigating T cell−inflammation in pancreatic cancer
RI-MUHC leads study to identify a novel mechanism driving aggressive prostate cancer
This international research collaboration may lead to a shift in the clinical management of patients...
$6.7 million to study the impacts of COVID-19 on children
Health Minister Jean-Yves Duclos visits Montreal to announce a new investment in pediatric research and to congratulate researcher...
Immunotherapy showing significant advancements in lung cancer treatment
Phase 3 clinical trial of neoadjuvant nivolumab leads to practice-changing results
Where immune cells are located is critical for cancer immune therapy, a new study shows
An innovative new approach highlights the relevance of immune cells’ position within melanoma to inform on a...
RI-MUHC team receives Discovery of the Year Award from Québec Science magazine
Jean-Jacques Lebrun’s team at the RI-MUHC has won the 2021 Québec Science Discovery of the Year Award...
RI-MUHC trainee honoured by the American Association for Cancer Research
Yasmine Benslimane is investigating how the female hormone estrogen influences the spread of colon cancer...
Fall 2021 CIHR competition results
RI-MUHC teams received $9.5 million in project funding